Gibson Energy Inc. (OTCMKTS:GBNXF) Given Average Recommendation of “Buy” by Analysts

Share on StockTwits

Gibson Energy Inc. (OTCMKTS:GBNXF) has been given an average recommendation of “Buy” by the ten research firms that are presently covering the firm, Marketbeat reports. Four analysts have rated the stock with a hold rating and six have assigned a buy rating to the company.

Several equities analysts recently issued reports on the company. Raymond James upgraded Gibson Energy from a “mkt perform” rating to an “outperform” rating in a research note on Wednesday, May 8th. JPMorgan Chase & Co. upgraded Gibson Energy from a “neutral” rating to an “overweight” rating in a research note on Monday, June 17th. Finally, Credit Suisse Group lowered Gibson Energy from an “outperform” rating to a “neutral” rating in a research note on Thursday, April 25th.

GBNXF remained flat at $$17.26 on Friday. Gibson Energy has a 52-week low of $13.10 and a 52-week high of $18.50. The firm’s 50 day moving average is $17.85 and its 200-day moving average is $16.96.

Gibson Energy Company Profile

Gibson Energy Inc engages in the gathering, storage, optimization, processing, and marketing of crude oil and refined products in North America. It operates through Infrastructure and Wholesale segments. The Infrastructure segment operates a network of infrastructure assets that include oil terminals, rail loading and unloading facilities, injection stations, gathering pipelines, and a crude oil processing facility, as well as procession, recovery, and disposal terminals.

Featured Story: How can investors find ex-dividend dates?

Analyst Recommendations for Gibson Energy (OTCMKTS:GBNXF)

Receive News & Ratings for Gibson Energy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gibson Energy and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Analysts Set $12.00 Price Target for KITOV PHARMA LT/S
Analysts Set $12.00 Price Target for KITOV PHARMA LT/S
-$0.19 Earnings Per Share Expected for ENDRA Life Sciences Inc  This Quarter
-$0.19 Earnings Per Share Expected for ENDRA Life Sciences Inc This Quarter
Melrose Industries PLC  Receives GBX 245 Consensus Price Target from Analysts
Melrose Industries PLC Receives GBX 245 Consensus Price Target from Analysts
Prospera Financial Services Inc Takes Position in Invesco Trust for Investment GradeMncpls
Prospera Financial Services Inc Takes Position in Invesco Trust for Investment GradeMncpls
VANGUARD SCOTTS/VANGUARD RUSSELL 20  Shares Sold by Private Advisor Group LLC
VANGUARD SCOTTS/VANGUARD RUSSELL 20 Shares Sold by Private Advisor Group LLC
Private Advisor Group LLC Increases Stock Holdings in Invesco BulletShares 2019 Corporate Bond ETF
Private Advisor Group LLC Increases Stock Holdings in Invesco BulletShares 2019 Corporate Bond ETF


 
© 2006-2019 Zolmax.